Helix BioMedix, Inc. has created an extensive proprietary library of bioactive peptides based upon the diversity of structure, origin and activity of this class of innate immunity element.
Helix BioMedix, Inc. has created an extensive proprietary library of bioactive peptides based upon the diversity of structure, origin and activity of this class of innate immunity element.
Helix BioMedix is a biopharmaceutical company focused on drug development for treatment of rare dermatological diseases, such as xeroderma pigmentosum. Our legacy R&D consists of an extensive proprietary library of patented bioactive peptides based on the body’s innate immunity.
©2023 HELIX BIOMEDIX, INC.
ALL RIGHTS RESERVED